UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
July 29, 2010

NEOGENOMICS, INC.
(Exact name of registrant as specified in its charter)

Nevada
  
333-72097
  
74-2897368
(State or other jurisdiction of
  
(Commission File Number)
  
(I.R.S. Employer
incorporation)
      
Identification No.)
 
12701 Commonwealth Drive, Suite 9, Fort Myers,
Florida
  
33913 
(Zip Code)
(Address of principal executive offices)
  

(239) 768-0600
 (Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Item 2.02.           Results of Operations and Financial Condition.
 
On July 29, 2010, NeoGenomics, Inc. (the “Company”) issued a press release regarding the Company’s results of operations for the quarter ended June 30, 2010. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
Item 9.01.            Financial Statements and Exhibits.
 
(a)          Not applicable
 
(b)          Not applicable
 
(c)          Not applicable
 
(d)         Exhibits.
 
99.1         Press Release of NeoGenomics, Inc. dated July 29, 2010

 
- 2 -
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
NEOGENOMICS, INC.
   
By:
/s/ George Cardoza
 
George Cardoza
 
Chief Financial Officer

Date: July 29, 2010

 
- 3 -
 

Exhibit Index
 
Exhibit No.
  
Description
     
99.1
  
Press Release of NeoGenomics, Inc. dated July 29, 2010
 
 
- 4 -